Stem Cells World Congress
Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Reports

Irreversible chromosome damage accumulates rapidly in the absence of ATM kinase activity

Jason S. White, Serah Choi and Christopher J. Bakkenist

volume 7 | issue 9

1 May 2008
Pages: 1277 - 1284

Purchase article for $19

Subscribe to this journal for $129/year

Mutations in the ATM kinase cause the neurodegenerative disorder ataxia telangiectasia (A-T) and affected individuals are exquisitely radiation-sensitive and cancer-prone. Cells derived from A-T individuals contain chromosome aberrations and exhibit profound cellular radiosensitivity. ATM is an apical kinase critical for the activation of cell cycle checkpoints and the induction of apoptosis in irradiated cells. However, defects in these pathways are insufficient to account for the chromosomal instability seen in A-T cells. We show here that the small molecule KU55933 can be used as a “molecular switch” to selectively and transiently inhibit ATM kinase activity in cells. We subsequently show that the cellular radiosensitization seen when ATM kinase activity is inhibited for one hour following exposure to γ-rays, accounts for over 70% of the total cellular radiosensitization seen when ATM kinase activity is inhibited for 17h. Finally, we show that inhibition of ATM kinase activity for one hour following exposure to irradiation doubles the number of chromosome aberrations occurring in late-S- and G2-, but not M-phase, cells. These observations are unexpected and suggest that irreversible chromosome damage accumulates very rapidly when ATM kinase activity is transiently inhibited following irradiation. We propose that we have revealed an essential, yet previously undescribed, role for ATM kinase in suppressing chromosomal instability

Authors

Jason S. White

University of Pittsburgh School of Medicine; Pittsburgh, PA

Serah Choi

University of Pittsburgh School of Medicine; Pittsburgh, PA

Christopher J. Bakkenist

University of Pittsburgh School of Medicine; Pittsburgh, PA


Purchase article for $19

Subscribe to this journal for $129/year